K08670658
Kromasil® C18 HPLC Column
5 μm particle size, pore size 100 Å, L × I.D. 125 mm × 4 mm
Synonym(s):
Kromasil C18
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Agency
suitable for USP L1
product line
Kromasil®
manufacturer/tradename
Kromasil® KR100-5-C18-4.0X125
availability
available only in USA, Canada and Puerto Rico
technique(s)
HPLC: suitable
L × I.D.
125 mm × 4 mm
matrix active group
C18 (octadecyl) phase
particle size
5 μm
pore size
100 Å
application(s)
food and beverages
separation technique
reversed phase
Looking for similar products? Visit Product Comparison Guide
Related Categories
Application
- QbD-Engineered Development and Validation of a RP-HPLC Method for Simultaneous Estimation of Rutin and Ciprofloxacin HCl in Bilosomal Nanoformulation.: This study leverages the Kromasil® C18 HPLC Column to develop a robust, quality-by-design (QbD) engineered method for simultaneous estimation of rutin and ciprofloxacin, enhancing analytical accuracy in pharmaceutical formulations (Shamim et al., 2023).
- Green analytical chemistry and experimental design: a combined approach for the analysis of zonisamide.: Highlights the use of the Kromasil® C18 HPLC Column in implementing green analytical chemistry principles for the analysis of zonisamide, contributing to sustainable laboratory practices (Elsheikh et al., 2023).
- Simple high-performance liquid chromatography-ultraviolet method for simultaneous separation and detection of 14 bisphenol pollutants in building materials.: Demonstrates the efficacy of the Kromasil® C18 HPLC Column in environmental analysis, particularly for the detection of bisphenol pollutants in construction materials, addressing significant environmental health concerns (Han et al., 2023).
- Development and Validation for Quantification of 7-Nitroso Impurity in Sitagliptin by Ultraperformance Liquid Chromatography with Triple Quadrupole Mass Spectrometry.: This paper uses the Kromasil® C18 HPLC Column for the sensitive detection and quantification of impurities in pharmaceutical products, ensuring drug safety and compliance with regulatory standards (Chittireddy et al., 2022).
- Simple and Sensitive RP-HPLC and UV Spectroscopic Methods for the Determination of Remogliflozin Etabonate in Pure and Pharmaceutical Formulations.: Utilizes the Kromasil®C18 HPLC Column to establish a simple and sensitive method for the analysis of Remogliflozin, aiding in the quality control and development of diabetes medication (Itigimatha et al., 2022).
Legal Information
Kromasil is a registered trademark of EKA Chemicals AB
Regulatory Information
新产品
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service